Digital rectal examination is not useful as a solitary screening tool for prostate cancer in young men from examination of prostate Watch Video
Preview(s):
Gallery
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Description: Prof Peter Albers speaks to ecancer about the results from the PROBASE trial. Digital rectal examination (DRE), in most guidelines, is a recommended screening tool for early prostate cancer detection.nnPROBASE is a randomised screening trial that has accrued younger men to test a risk-adapted screening strategy using a baseline prostate specific antigen value with the additional offer of DRE in a large sub-cohort of participants.nnProf Albers says that the trial showed that DRE is not useful as
Play Video: (Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)